Skip to search formSkip to main contentSkip to account menu

KB 2796

Known as: KB-2796 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Abstract NMDA receptor antagonists have been demonstrated to be neuroprotective in focal cerebral ischemia and are supposed to… 
1998
1998
NMDA receptor antagonists have been demonstrated to be neuroprotective in focal cerebral ischemia and are supposed to prevent… 
1995
1995
1 We examined the effects of two Ca2+ channel blockers, lomerizine (KB‐2796) and flunarizine, on the cortical hypoperfusion… 
Highly Cited
1993
1993
1993
The effects of the novel calcium channel antagonist KB-2796, other calcium channel antagonists, an N-methyl-D-aspartate (NMDA… 
1991
1991
Abstract— The effects of KB‐2796, a new diphenylpiperazine analogue, on [3H]nitrendipine ([3H]NTD) binding, KCl‐induced… 
1990
1990
The protective effect of KB-2796, a new calcium antagonist possessing a selective vasodilator activity on cerebral vessels in… 
1990
1990
The effects of a new calcium entry blocker, KB-2796, on cerebral and peripheral circulation were compared with those of four… 
Highly Cited
1989
Highly Cited
1989
Abstract: The effects of a new calcium channel blocker, l‐[bis(4‐fluorophenyl)methyl]‐4‐(2,3,4‐trimethoxybenzyl)‐piperazine… 
1988
1988
The effect of KB-2796, a new diphenylpiperazine calcium antagonist, on [3H]nitrendipine ([3H]NTD) binding was investigated in…